Connect with us
Pharmaceutical giant Jazz recently announced that its leading cannabinoid treatment, Epidyolex, failed clinical trials...
Synthetic cannabinoids are easily accessible in various parts of the world, including Portugal, despite being potentially dangerous and several countries having already banned them,...
A preclinical trial by researchers at the University of Arizona Comprehensive Center for Pain & Addiction highlights the potential of cannabis terpenes in treating...
The results of a new clinical trial show that CBG (Cannabigerol) was effective in reducing anxiety and stress, as well as improving...
Last week, Infarmed – National Authority for Medicines and Health Products, IP approved two new ACMs (Authorization for Placing on the Market) for preparations...
The German Joint Federal Committee (Gemeinsamer Bundesausschuss, or G-BA) this week announced exceptions to the approval requirements for prescribing medical cannabis under...
Infarmed – National Authority for Medicines and Health Products, IP approved two new ACMs (Authorization for Placing on the Market) for preparations based on...
A recent study on CBD products in Portugal reveals alarming disparities between advertised and real cannabinoid content, highlighting the urgency of...
American pediatrician Bonni Goldstein is warning of the attempted ban on medicines derived from natural CBD in California. The California government proposed...
Polydrug users, individuals who consume several substances, often turn to cannabis as a way to reduce their consumption of stimulants, such as methamphetamines, reveals a...
Watch the Documentary "Patients"
